SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

OS Therapies Inc
Date: June 2, 2025 · CIK: 0001795091 · Accession: 0001213900-25-050099

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-287569

Date
June 2, 2025
Author
OS Therapies Incorporated
Form
CORRESP
Company
OS Therapies Inc

Letter

Re: OS Therapies Incorporated Registration Statement on Form S-1 (No. 333-287569)

EMAIL: SFeldman@olshanlaw.com

DIRECT DIAL: 212.451.2234

June 2, 2025

VIA EDGAR

U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549

Attn.: Joshua Gorsky Office of Life Sciences

Ladies and Gentlemen:

On behalf of OS Therapies Incorporated, a Delaware corporation (the "Company"), we enclose the Company's request for acceleration of the above-referenced Registration Statement to 4:30 p.m., Eastern time, on Friday, June 6, 2025, or as soon as practicable thereafter.

Please advise the undersigned of the effectiveness of the Registration Statement.

Very truly yours,

/s/ Spencer G. Feldman

Spencer G. Feldman

cc: Paul A. Romness, MPH

June 2, 2025

U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549

Attn.: Joshua Gorsky Office of Life Sciences

Re: OS Therapies Incorporated Registration Statement on Form S-1 (No. 333-287569)

Ladies and Gentlemen:

OS Therapies Incorporated hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:30 p.m., Eastern time, on Friday, June 6, 2025, or as soon as practicable thereafter.

Very truly yours,
OS Therapies Incorporated

Show Raw Text
CORRESP
 1
 filename1.htm

 EMAIL: SFeldman@olshanlaw.com

 DIRECT DIAL: 212.451.2234

 June 2, 2025

 VIA EDGAR

 U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

 Attn.: Joshua Gorsky
 Office of Life Sciences

 Re: OS Therapies Incorporated
 Registration Statement on Form S-1 (No. 333-287569)

 Ladies and Gentlemen:

 On behalf of OS Therapies
Incorporated, a Delaware corporation (the "Company"), we enclose the Company's request for acceleration of the above-referenced
Registration Statement to 4:30 p.m., Eastern time, on Friday, June 6, 2025, or as soon as practicable thereafter.

 Please advise the undersigned
of the effectiveness of the Registration Statement.

 Very truly yours,

 /s/ Spencer G. Feldman

 Spencer G. Feldman

 cc: Paul A. Romness, MPH

 June 2, 2025

 U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

 Attn.: Joshua Gorsky
 Office of Life Sciences

 Re: OS Therapies Incorporated
 Registration Statement on Form S-1 (No. 333-287569)

 Ladies and Gentlemen:

 OS Therapies Incorporated
hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective
at 4:30 p.m., Eastern time, on Friday, June 6, 2025, or as soon as practicable thereafter.

 Very truly yours,

 OS Therapies Incorporated

 By:
 /s/ Paul A. Romness

 Paul A. Romness

 President and Chief Executive Officer